Jamieson Wellness (TSX:JWEL) stock was up 2% in 2019 as of early afternoon trading on January 25. Shares were up 1.2% year over year.
Jamieson stock took a hit after its third-quarter earnings release in November.
In the third quarter, the company posted sales that missed expectations largely due to a decrease in Strategic Partners revenue. This segment was negatively impacted due to timing of ingredients from a specific partner that moved the volume to the fourth quarter.
The company is expected to release its fourth-quarter results in late February. Shares had an RSI of 49 as of this writing, putting the stock in neutral territory in the middle of a significant bump up for the TSX in January.
Jamieson also offers a quarterly dividend of $0.09 per share which represents a modest 1.5% yield. The stock had posted impressive growth since its IPO before the Q3 2018 setback. Should investors be betting on a return to all-time highs in 2019?
Global supplement sales are forecast to continue to grow at an attractive clip into the next decade. Jamieson’s international expansion is aimed at taking advantage of this trend, and its results have been promising.
As expected, Jamieson managed to climb out of 52-week lows, but the stock is still a decent value in late January. Shares have benefited from the early January bump, so investors may want to await a pullback closer to the $20 mark before stacking ahead of its fourth-quarter earnings release.
